ARK Investment Management’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Hold
0
278
2022
Q2
Sell
-1,170,111
Closed -$27.2M 353
2022
Q1
$52.5M Sell
1,170,111
-43,096
-4% -$1.78M 0.22% 66
2021
Q4
$52M Sell
1,213,207
-844,660
-41% -$44.1M 0.16% 84
2021
Q3
$137M Sell
2,057,867
-467,746
-19% -$32.9M 0.33% 57
2021
Q2
$185M Sell
2,525,613
-71,675
-3% -$4.73M 0.34% 64
2021
Q1
$178M Buy
2,597,288
+528,696
+26% +$39.7M 0.35% 68
2020
Q4
$139M Buy
2,068,592
+1,620,867
+362% +$87.9M 0.37% 62
2020
Q3
$23M Sell
447,725
-26,045
-5% -$1.16M 0.14% 84
2020
Q2
$17.9M Buy
473,770
+253,318
+115% +$8.66M 0.19% 65
2020
Q1
$6.57M Buy
220,452
+14,438
+7% +$436K 0.16% 68
2019
Q4
$7.08M Buy
206,014
+39,927
+24% +$976K 0.18% 66
2019
Q3
$3M Buy
+166,087
New +$3.68M 0.07% 88

Other funds holding CSTL